Innate Pharma IPHA Q1 2026 Earnings Deep EPS Miss Weighs on Shares as Pipeline Progress Remains in Focus AVNS Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Revenue Uncertainty BIIB Q1 2026 Earnings Strong EPS Surprise Drives Stock Higher OCCIO Q1 2026 Earnings Preferred Stock Reports Negative EPS of 076 Sharply Missing Estimates HEI Q1 2026 Earnings EPS Beats Estimates Shares Rise 26 Global Partners GLP Q1 2026 Earnings Massive EPS Beat of 455 Driven by Operational Strength